The 'Personalize My treatment' (PMT) platform is a novel form of biobanking in which cancer patients willingly consent to provide residual, clinical samples (surplus after diagnostic testing) of their tumors for cancer research, to give access to their medical record for data collection and then followed prospectively throughout the trajectory of their illness. They further willingly consent to be recontacted for being informed of other research projects, including clinical trials.
Study Type
OBSERVATIONAL
Enrollment
10,000
Tom Baker Cancer Centre
Calgary, Alberta, Canada
Cross Cancer Institute
Edmonton, Alberta, Canada
Centre Hospitalier Universitaire Dr-Georges-L.-Dumont
The primary objective of PMT is to create a collection of cancer patient biospecimens and annotated data that will be used for clinical trial matching and to advance cancer research.
Time frame: Longitudinal
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Moncton, New Brunswick, Canada
The Moncton Hospital
Moncton, New Brunswick, Canada
QE II Health Sciences Centre
Halifax, Nova Scotia, Canada
London Health Science Centre
London, Ontario, Canada
The Ottawa Hospital
Ottawa, Ontario, Canada
Odette Cancer Centre - Sunnybrook Hospital
Toronto, Ontario, Canada
Centre hospitalier de l'Université de Montréal
Montreal, Quebec, Canada
Jewish General Hospital
Montreal, Quebec, Canada
...and 4 more locations